US pharma giant Merck backs healthcare marketplace HD in Southeast Asia
Merck’s Top-Seller Cements Status in Hard-to-Treat Breast Cancer
Merck KGaA Sees Semiconductor Business Rebound Amid AI Boom
J&J, Merck, and Bristol Myers Squibb spend billions more on executives and stockholders than on R&D — Senate report points to greed and ‘patent thickets’ as key reasons for high prices
Merck Navigates Chip Geopolitics With ‘China For China’ Strategy
